As shown in Fig. 2a, PCNA-labeling indices of colonic adenocarcinomas in mice treated with 100- and 400-ppm nelumal A were markedly less than those of the AOM/DSS-treated group. This evidence concerns the gene PCNA and colon adenocarcinoma.